Drug Combo Found Helpful in End-of-Life Delirium (CME/CE)
(MedPage Today) -- Lorazepam add-on lessened agitation; but were patients overtreated? (Source: MedPage Today State Required CME)
Source: MedPage Today State Required CME - September 21, 2017 Category: Consumer Health News Source Type: news
Lorazepam Recalled Due to Incorrect Dose Markings (FREE)
By Kristin J. Kelley
Edited by Richard Saitz, MD, MPH, FACP, DFASAM
Thirteen lots of the anxiety medication lorazepam (oral concentrate, USP 2 mg/mL) … (Source: Physician's First Watch current issue)
Source: Physician's First Watch current issue - August 17, 2017 Category: Primary Care Source Type: news
Amneal Pharmaceuticals Issues Voluntary Nationwide Recall of Lorazepam Oral Concentrate, USP 2mg/mL, Due to Misprinted Dosing Droppers Supplied with the Product
Amneal Pharmaceuticals LLC is voluntarily recalling 13 lots of Lorazepam Oral Concentrate, USP 2mg/mL, to the Consumer level due to a defect in the dropper markings. The Lorazepam Oral Concentrate, USP 2mg/mL, product is packaged with a dosing dropper, supplied to Amneal by a third party. (Source: Food and Drug Administration)
Source: Food and Drug Administration - August 16, 2017 Category: Food Science Source Type: news
Amneal Pharmaceuticals issues voluntary recall of lorazepam droppers
Amneal Pharmaceuticals said today that it is voluntarily recalling 13 lots of its oral lorazepam product due to a defect in the dosing dropper.
In some cases, the dropper is printed with the dose markings in reverse order or has no dose markings at all, according to the Bridgewater, N.J.-based company. So far, no adverse events related to the dropper defect have been reported.
Get the full story at our sister site, Drug Delivery Business News.
The post Amneal Pharmaceuticals issues voluntary recall of lorazepam droppers appeared first on MassDevice. (Source: Mass Device)
Source: Mass Device - August 15, 2017 Category: Medical Devices Authors: Sarah Faulkner Tags: Drug-Device Combinations Neurological Pharmaceuticals Recalls amnealpharmaceuticals Source Type: news
FDA accepts Axium ’ s orphan designation request for intranasal Truveta
Axium Pharmaceuticals said today that the FDA accepted its orphan designation request for the intranasal administration of lorazepam, Truveta, in the treatment of Lennox-Gastaut syndrome.
The High Point, N.C.-based company is developing a novel intranasal administration device for new formulations of existing drugs. Axium said the device is designed to bring about rapid onset of a therapeutic effect with minimal side effects, while boosting bio-availability.
Get the full story at our sister site, Drug Delivery Business News.
The post FDA accepts Axium’s orphan designation request for intranasal Truveta appeared firs...
Source: Mass Device - July 11, 2017 Category: Medical Devices Authors: Sarah Faulkner Tags: Drug-Device Combinations Food & Drug Administration (FDA) axiumpharmaceuticals Source Type: news
Drug Shortages and Rapid Price Escalation: The Latest on the Crisis
The American health system is now into the seventh year of an unprecedented and unplanned shortage of emergency medications. The causes of the shortage continue to be debated, but the root cause is the American manufacturers of intravenous medications, and disputes between those manufacturers and the Federal agencies that oversee drug supply and manufacturing practices (FDA and DEA), over safe manufacturing and quality processes.
The Crisis
There are now life-threatening problems with medication supplies for EMS providers across all classes of emergency medicines. As of June 26, 2017, there are 69 preparations of 28 emerge...
Source: JEMS Operations - July 6, 2017 Category: Emergency Medicine Authors: James J. Augustine, MD, FACEP Tags: News Operations Source Type: news
Drug Shortages and Rapid Price Escalation: The Latest on the Crisis
The American health system is now into the seventh year of an unprecedented and unplanned shortage of emergency medications. The causes of the shortage continue to be debated, but the root cause is the American manufacturers of intravenous medications, and disputes between those manufacturers and the Federal agencies that oversee drug supply and manufacturing practices (FDA and DEA), over safe manufacturing and quality processes.
The Crisis
There are now life-threatening problems with medication supplies for EMS providers across all classes of emergency medicines. As of June 26, 2017, there are 69 preparations of 28 emerge...
Source: JEMS: Journal of Emergency Medical Services News - July 6, 2017 Category: Emergency Medicine Authors: James J. Augustine, MD, FACEP Tags: News Operations Source Type: news
Feel the pain: Greater Washington ’s economy has plenty to lose from deep NIH cuts
Out of a large Rockville office building, researchers are studying whether certain drugs created for adults — anxiety drug Ativan or the antibiotic best known as Merrem — are safe for children.
The examination has resulted in four drug label changes by the Food and Drug Administration so far, including updated safety and efficacy guidelines for use in children. Four more drugs are under similar revie w.
“If you have a child, you understand that is pretty important,” said Anne Lindblad, CEO… (Source: bizjournals.com Health Care News Headlines)
Source: bizjournals.com Health Care News Headlines - March 31, 2017 Category: Health Management Authors: Tina Reed Source Type: news
False negative on a proven involuntary intoxication in two children with lorazepam - Feliu C, Guillemin H, Gozalo C, Fouley A, Marty H, Millart H, Djerada Z.
Children aged between 1 to 4 years are the most at risk of unintentional poisonings. Benzodiazepines are the most medicine often cause of the poisoning. Among the twenty-two most prescribed benzodiazepines in France, lorazepam ranks fifth behind zolpidem, ... (Source: SafetyLit)
Source: SafetyLit - January 14, 2017 Category: Global & Universal Tags: Age: Infants and Children Source Type: news
Ativan (lorazepam) vs. Valium (diazepam)
Title: Ativan (lorazepam) vs. Valium (diazepam)Category: MedicationsCreated: 12/28/2016 12:00:00 AMLast Editorial Review: 12/28/2016 12:00:00 AM (Source: MedicineNet Medications General)
Source: MedicineNet Medications General - December 28, 2016 Category: Drugs & Pharmacology Source Type: news
Ativan vs. Xanax
Title: Ativan vs. XanaxCategory: MedicationsCreated: 12/14/2016 12:00:00 AMLast Editorial Review: 12/28/2016 12:00:00 AM (Source: MedicineNet Medications General)
Source: MedicineNet Medications General - December 28, 2016 Category: Drugs & Pharmacology Source Type: news
Ativan (lorazepam)
Title: Ativan (lorazepam)Category: MedicationsCreated: 12/31/1997 12:00:00 AMLast Editorial Review: 11/9/2016 12:00:00 AM (Source: MedicineNet Medications General)
Source: MedicineNet Medications General - November 9, 2016 Category: Drugs & Pharmacology Source Type: news
Ativan (Lorazepam) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - September 27, 2016 Category: Drugs & Pharmacology Source Type: news
Alcoholics who quit completely do better than those who dabble. I'm not surprised | David Ferguson
I tried, and failed, repeatedly to control my intake of intoxicating substances. Eventually I decided total sobriety was the only wayIn my last week of using drugs in the summer of 2005, I had a moment of clarity during a binge that combined codeine cough syrup, Ativan pills and ground-up Oxycontin that I was snorting. I was stumbling around the room – I was always a mess of bruises from head to foot in those days – trying to decide whether or not to take all the rest of the Ativan in the bottle when it occurred to me to ask myself, “Why is it that I can never get high enough? What exactly is it I’m trying not to f...
Source: Guardian Unlimited Science - September 19, 2016 Category: Science Authors: David Ferguson Tags: Alcoholism Science Source Type: news
FDA orders stronger warnings about risk of using opioid painkillers with certain anti-anxiety drugs
The Food and Drug Administration is issuing strong new warnings that the combined use of opioid medications and benzodiazepines, a class of anti-anxiety medications better known by such commercial names as Xanax and Ativan, can dangerously suppress breathing and cause coma or death.The drug safety... (Source: Los Angeles Times - Science)
Source: Los Angeles Times - Science - August 31, 2016 Category: Science Authors: Melissa Healy Source Type: news
